Loading fund overlap…
17 of 97 unique stocks in common · Jaccard: 17.5%
A weighted portfolio overlap of 39.21% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹39.21 is allocated to the exact same companies at the same relative proportions. The schemes share 17 common holdings.
The largest overlapping asset in their portfolios is ICICI Bank, which commands a weight of 8.26% in Aditya Birla Sun Life ESG Integration Strategy Fund and 5.84% in UTI Value Fund. Holding both schemes increases your concentration in ICICI Bank rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Aditya | in UTI |
|---|---|---|
| ICICI BankBanks | 8.26% | 5.84% |
| HDFC BankBanks | 4.60% | 8.28% |
| Bharti AirtelTelecom - Services | 4.15% | 4.35% |
| Kotak Mahindra BankBanks | 3.72% | 3.73% |
| Axis BankBanks | 3.68% | 3.82% |
| InfosysIT - Software | 3.56% | 3.39% |
| State Bank of IndiaBanks | 3.23% | 3.44% |
| Mahindra & MahindraAutomobiles | 2.24% | 3.01% |
| ICICI Lombard General Insurance CompanyInsurance | 1.69% | 1.55% |
| IndusInd BankBanks | 1.13% | 1.70% |
| Varun BeveragesBeverages | 1.82% | 1.01% |
| Samvardhana Motherson InternationalAuto Components | 1.75% | 0.99% |
| Tech MahindraIT - Software | 0.93% | 2.60% |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 0.93% | 1.46% |
| Dalmia BharatCement & Cement Products | 0.67% | 1.04% |
| CiplaPharmaceuticals & Biotechnology | 0.62% | 1.75% |
| Aditya Birla Lifestyle BrandsRetailing | 1.47% | 0.51% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.